Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2018
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- 11 Oct 2018 Status changed from recruiting to withdrawn prior to enrolment due to slow accrual.
- 31 Aug 2018 Biomarkers information updated
- 12 Dec 2017 Status changed from not yet recruiting to recruiting.